COVID-19 in bone marrow transplant recipients: reflecting on a single centre experience.
作者信息
Kanellopoulos Alexandros, Ahmed Maria Z, Kishore Bhuvan, Lovell Richard, Horgan Claire, Paneesha Shankara, Lloyd Rebecca, Salhan Beena, Giles Hannah, Chauhan Saleena, Venkatadasari Indrani, Khakwani Muhammad, Murthy Vidhya, Xenou Evgenia, Dassanayake Hansini, Srinath Swathy, Kaparou Maria, Nikolousis Emmanouil
机构信息
Birmingham Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
出版信息
Br J Haematol. 2020 Jul;190(2):e67-e70. doi: 10.1111/bjh.16856. Epub 2020 Jun 23.
Abstract
摘要
相似文献
1
COVID-19 in bone marrow transplant recipients: reflecting on a single centre experience.骨髓移植受者中的新型冠状病毒肺炎：单中心经验反思
Br J Haematol. 2020 Jul;190(2):e67-e70. doi: 10.1111/bjh.16856. Epub 2020 Jun 23.
2
Pharmacist-driven education for solid organ transplant recipients in the COVID-19 era.药剂师主导的针对新冠疫情时代实体器官移植受者的教育
Clin Transplant. 2020 Aug;34(8):e14013. doi: 10.1111/ctr.14013. Epub 2020 Jul 6.
3
Covid-19 and Kidney Transplantation.新冠病毒-19与肾移植
N Engl J Med. 2020 Jun 18;382(25):2475-2477. doi: 10.1056/NEJMc2011117. Epub 2020 Apr 24.
4
COVID-19 and liver transplantation.COVID-19 与肝移植。
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):526-528. doi: 10.1038/s41575-020-0347-z.
5
Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve.免疫抑制移植受者中的新型冠状病毒-19（COVID-19）：# 减缓传播速度。
Am J Transplant. 2020 Jul;20(7):1765-1767. doi: 10.1111/ajt.15890. Epub 2020 Apr 12.
6
A kidney transplant recipient with nausea, vomiting, and diarrhea after a recent COVID-19 exposure.一名肾移植受者近期接触新冠病毒后出现恶心、呕吐和腹泻症状。
Am J Transplant. 2020 Sep;20(9):2618-2620. doi: 10.1111/ajt.16184.
7
Novel coronavirus 2019 pneumonia in a kidney transplant recipient.肾移植受者 2019 年新型冠状病毒肺炎。
Am J Transplant. 2020 Sep;20(9):2599-2601. doi: 10.1111/ajt.15999. Epub 2020 Jun 12.
8
COVID-19 in kidney transplant recipients.肾移植受者中的新型冠状病毒肺炎
Am J Transplant. 2020 Jul;20(7):1941-1943. doi: 10.1111/ajt.15891. Epub 2020 Apr 12.
9
Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report.肾移植受者 SARS-CoV-2 肺炎的免疫抑制治疗维持：一例报告。
Am J Transplant. 2020 Jul;20(7):1922-1924. doi: 10.1111/ajt.15920. Epub 2020 May 8.
10
Haemophagocytosis in bone marrow aspirates in patients with COVID-19.新型冠状病毒肺炎患者骨髓穿刺物中的噬血细胞现象
Br J Haematol. 2020 Jul;190(2):e70-e73. doi: 10.1111/bjh.16860. Epub 2020 Jun 12.
引用本文的文献
1
Identifying risk factors for severe omicron infection in allogeneic hematopoietic stem cell transplant recipients with hematologic malignancies.识别血液恶性肿瘤的异基因造血干细胞移植受者中奥密克戎感染严重的风险因素。
Cancer Rep (Hoboken). 2024 Jun;7(6):e2103. doi: 10.1002/cnr2.2103.
2
Characteristics and Outcomes of Stem Cell Transplant Patients during the COVID-19 Era: A Systematic Review and Meta-Analysis.COVID-19 大流行期间干细胞移植患者的特征与结局：一项系统综述和荟萃分析
Healthcare (Basel). 2024 Feb 23;12(5):530. doi: 10.3390/healthcare12050530.
3
Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy.造血细胞移植和嵌合抗原受体 T 细胞治疗患者中 SARS-CoV2 奥密克戎变异株的结局和管理。
Transplant Cell Ther. 2024 Jan;30(1):116.e1-116.e12. doi: 10.1016/j.jtct.2023.09.027. Epub 2023 Oct 6.
4
Prolonged SARS-CoV-2 infection during autologous hematopoietic stem cell transplantation from Hodgkin's lymphoma: a case report.自体造血干细胞移植治疗霍奇金淋巴瘤后持续性 SARS-CoV-2 感染：病例报告。
Pan Afr Med J. 2023 Mar 16;44:133. doi: 10.11604/pamj.2023.44.133.36277. eCollection 2023.
5
Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry.CMV 血清阳性的异基因造血干细胞移植患者 COVID-19 患者的转归改善和死亡率升高：来自欧洲血液和骨髓移植学会登记处传染病工作组的研究。
Front Immunol. 2023 Mar 7;14:1125824. doi: 10.3389/fimmu.2023.1125824. eCollection 2023.
6
Clinical efficacy analysis of mesenchymal stem cell therapy in patients with COVID-19: A systematic review.间充质干细胞疗法治疗新型冠状病毒肺炎患者的临床疗效分析：一项系统评价
World J Clin Cases. 2022 Sep 26;10(27):9714-9726. doi: 10.12998/wjcc.v10.i27.9714.
7
The Cause-Effect Dilemma of Hematologic Changes in COVID-19: One Year after the Start of the Pandemic.新冠疫情爆发一年后：COVID-19血液学变化的因果困境
Hematol Rep. 2022 Mar 28;14(2):95-102. doi: 10.3390/hematolrep14020014.
8
A Portrait of SARS-CoV-2 Infection in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review of the Literature.造血干细胞移植患者中 SARS-CoV-2 感染的特征：系统文献复习。
Curr Oncol. 2022 Jan 13;29(1):337-349. doi: 10.3390/curroncol29010030.
9
Pulmonary aspergillosis and cryptococcosis as a complication of COVID-19.肺曲霉病和隐球菌病作为新冠病毒感染疾病（COVID-19）的并发症
Med Mycol Case Rep. 2022 Mar;35:22-25. doi: 10.1016/j.mmcr.2022.01.003. Epub 2022 Jan 6.
10
COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune disease.自身免疫性疾病患者自体造血干细胞移植背景下的新型冠状病毒肺炎
Curr Res Transl Med. 2022 May;70(2):103332. doi: 10.1016/j.retram.2021.103332. Epub 2021 Dec 24.
本文引用的文献
1
COVID-19 outcomes in patients with hematologic disease.血液系统疾病患者的新型冠状病毒肺炎结局
Bone Marrow Transplant. 2020 Nov;55(11):2180-2184. doi: 10.1038/s41409-020-0931-4. Epub 2020 May 6.
2
The trinity of COVID-19: immunity, inflammation and intervention.COVID-19 的三位一体：免疫、炎症和干预。
Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28.
3
COVID-19 in persons with haematological cancers.COVID-19 与血液系统恶性肿瘤。
Leukemia. 2020 Jun;34(6):1637-1645. doi: 10.1038/s41375-020-0836-7. Epub 2020 Apr 24.
4
Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19.无症状传播，当前控制新冠疫情策略的致命弱点。
N Engl J Med. 2020 May 28;382(22):2158-2160. doi: 10.1056/NEJMe2009758. Epub 2020 Apr 24.
5
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.严重 COVID-19 中的细胞因子释放综合征：白细胞介素-6 受体拮抗剂托珠单抗可能是降低死亡率的关键。
Int J Antimicrob Agents. 2020 May;55(5):105954. doi: 10.1016/j.ijantimicag.2020.105954. Epub 2020 Mar 29.
6
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
7
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
8
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes.IFN-I 反应时机与病毒复制相对应决定了中东呼吸综合征冠状病毒感染的结果。
J Clin Invest. 2019 Jul 29;129(9):3625-3639. doi: 10.1172/JCI126363.
9
Multidimensional assessment of alveolar T cells in critically ill patients.危重症患者肺泡 T 细胞的多维评估。
JCI Insight. 2018 Sep 6;3(17). doi: 10.1172/jci.insight.123287.
10
Suppression of human B lymphocyte function by cyclophosphamide.环磷酰胺对人B淋巴细胞功能的抑制作用。
J Immunol. 1982 Jun;128(6):2453-7.
Zotero 插件